L2P Research Overview
- Founded
-
2015
- Status
-
Private
- Employees
-
12
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
1
L2P Research General Information
Description
Operator of a clinical research and development company intended to offer preclinical and toxicology services for developers of new pharmaceuticals. The company offers proprietary orthotopic and metastatic tumor models and the services include, quantitative whole-body animal imaging, small animal ultrasound MRI, CT scan, focal radiation, and other advanced technologies, enabling researchers to have a complete array of research services as required.
Contact Information
Website
www.l2plabs.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- 25 Health Sciences Drive
- Suite 114
- Stony Brook, NY 11790
- United States
+1 (844) 000-0000
L2P Research Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | 01-Dec-2017 | Completed | Startup |
L2P Research Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Operator of a clinical research and development company intended to offer preclinical and toxicology services for develo
Drug Discovery
Stony Brook, NY
12
As of 2022
000000000000
000000
voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occ
000000000 00000 (000
Hackensack, NJ
000
As of 0000
000.00
000000 - 000
000.00
000000
Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliq
00000 00000000000000
Madbury, Australia
00
As of 0000
00.00
0.000
0000-00-00
000000000000
Add Comparison
L2P Research Competitors (2)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Champions Oncology | Formerly VC-backed | Hackensack, NJ | 000 | 000.00 | 000000 - 000 | 000.00 |
| 000000000 | Private Equity-Backed | Madbury, Australia | 00 | 00.00 | 000000000000 |
L2P Research Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Suresh Anaganti Ph.D | Chief Executive Officer |
L2P Research Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
L2P Research Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Long Island High Technology Incubator | Accelerator/Incubator | 000 0000 | 000000 0 |
L2P Research Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000 0000000 | 28-Feb-2020 | 0000000000 | Other Healthcare Services | 000000 00 |